Abstract :
Dental work procedures are classified as a high risk of transmission and
contamination of the SARS-Cov-2 virus, therefore it is necessary to prevent and
control infection properly in carrying out work procedures. The SARS-Cov-2 virus
has been shown to have a very high transmission rate by spreading mostly through
respiratory droplets and through direct contact with surfaces contaminated with the
virus. Various evidence has shown that one of the human to human transmission
chains of the SARS-Cov virus -2 occurs in health care facilities, especially in dental
treatment procedures. Dentists are accustomed to using analgesia for the treatment
of their patients, but using longer doses and for periods of more than two weeks
presents special challenges. Special precautions are needed when using analgesia
in the current situation. The aim of this study is to determine the use of analgesic
drugs in dental clinics during the COVID-19 pandemi at the Kartika 01 clinic in
Surakarta in the period 2020. This research is a non-experimental descriptive study.
Data collection was carried out retrospectively. Sampling technique using saturated
sampling obtained data as many as 121 samples that meet the criteria. The results
of the study of Dental Polyclinic at Pratama Kartika 01 Surakarta, it can be
concluded that the most dental clinic patient characteristics are women (52.8%), the
most age group is 36-45 years (25.6 %), most comorbidities were hypertension
(72.7%), most pain medication was mefenamic acid (49.16%) and Paracetamol
(26,2%).